ITM Power's June Decision Trio: Can a 47% Rout Be Reversed by Hydrogen Policy Milestones?
11.06.2026 - 22:16:02 | boerse-global.de
The past fortnight has been a bruising one for shareholders in hydrogen electrolyser specialist ITM Power. After hitting a 52-week high of €2.58 (adjusted: 2.58 Euro? Actually the articles use Euro for stock price? Primary says 2,58 Euro, secondary says 2,58 Euro. Keep as EUR) in late May, the stock shed nearly half its value, touching a low of €1.35 before clawing back to €1.48 on Thursday — a one-day pop of over 9%. The recovery offers some relief, but the real test lies in a packed June calendar that could either validate or further undermine the recent sell-off.
The trigger for the slump was, paradoxically, a positive event. ITM Power was added to the MSCI United Kingdom Small Cap Index on 29 May. Hedge funds and arbitrageurs had piled in ahead of the index rebalancing, betting on passive buying from index trackers. Once the reallocation was complete, those speculative positions were unwound, unleashing a classic sell-the-fact rout. Goldman Sachs added to the pressure by reiterating its sell recommendation. On a seven-day basis the stock fell almost 31%, and the relative strength index dropped to 34 — deep into technically oversold territory.
Now the market’s attention shifts to three pivotal developments, all expected this month. The first is a ruling from the UK’s Competition and Markets Authority (CMA) on a government grant of £46.5 million for ITM’s “Chronos” production line. Chronos is designed to produce 2-MW electrolyser stacks that double the power density of earlier designs while slashing production costs by 40% and requiring half the floor space. A green light from the CMA would be a major step toward industrial-scale profitability and could quickly reframe the narrative around the stock.
Should investors sell immediately? Or is it worth buying ITM Power?
Alongside the CMA decision, two other catalysts are in play. ITM Power has been named as a preferred supplier for two projects in the second round of the UK’s hydrogen allocation auction (HAR2). Industry observers expect initial contract signals to emerge this month. Separately, Uniper is set to take a final investment decision on its Humber H2ub hydrogen hub at Killingholme, a large-scale project that would require ITM’s 20-MW POSEIDON modules. A positive outcome there would lock in a significant order and bolster the company’s project pipeline.
ITM has not been idle on other fronts. On 3 June it formalised a strategic partnership with Protium Green Solutions to jointly develop industrial green hydrogen plants across Britain, starting with the 15-MW Cromarty project in the Scottish Highlands. The company’s balance sheet also offers a cushion: Great British Energy holds a 10.4% stake following a £40 million investment, making it the second-largest shareholder. ITM sits on roughly £215 million in cash, enough to fund its expansion without resorting to a capital raise. Half-year results showed record revenues of £18 million, and the full-year forecast has been raised to between £40 million and £43 million.
Analyst opinion remains split. While Goldman Sachs maintains its bearish stance, several other houses have buy ratings on the stock, pointing to the long-term opportunity in hydrogen infrastructure. Despite the recent bloodbath, ITM Power shares are still up roughly 100% year to date, and the underlying uptrend remains intact. If the three June decisions break ITM’s way, the technical damage could be quickly forgotten — and the path back to the year’s high of €2.58 looks far less daunting.
Ad
ITM Power Stock: New Analysis - 11 June
Fresh ITM Power information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
